复方氨基酸胶囊治疗维持性血液透析患者营养不良及钙磷代谢障碍的有效性和安全性
|
|
吴望舒, 王旻洲, 宋阿会, 赵冰茹, 鲁嘉越, 洪文凯, 顾乐怡, 谢可炜, 陆任华
|
Efficacy and safety of compound amino acid capsules in the treatment of malnutrition and calcium and phosphorus metabolism disorders in maintenance hemodialysis patients
|
|
WU Wangshu, WANG Minzhou, SONG Ahui, ZHAO Bingru, LU Jiayue, HONG Wenkai, GU Leyi, XIE Kewei, LU Renhua
|
|
表6 2组血磷、血钙、1，25-（OH） 2-D3 及iPTH水平比较
|
Tab 6 Comparison of serum phosphorus， serum calcium， 1，25-（OH）2-D3 and iPTH between the two groups
|
|
| Group | Serum phosphorus/(mmol·L-1) | t/Z value① | P value① | Serum calcium/(mmol·L-1) | t/Z value① | P value① | 1,25-(OH)2-D3/(ng·mL-1) | t/Z value① | P value① | iPTH/ (pg·mL-1) | t/Z value① | P value① |
|---|
| Treatment group | | | | | | | | | | | | | | Baseline | 2.09±0.35 | ‒ | ‒ | 1.77±0.51 | ‒ | ‒ | 14.59±5.03 | ‒ | ‒ | 221.00 (248.45) | ‒ | ‒ | | 3-month | 1.67±0.45 | -2.743 | 0.013 | 2.35±0.21 | 4.581 | 0.000 | 18.03±5.02 | 4.504 | 0.000 | 156.60 (276.15) | -0.362 | 0.722 | | 6-month | 1.87±0.63 | -1.568② | 0.117 | 2.32±0.19 | 4.922 | 0.000 | 18.31±8.74 | -2.374② | 0.018 | 218.00 (379.25) | 1.045 | 0.308 | | 9-month | 1.81±0.38 | -2.103② | 0.035 | 2.42±0.25 | 5.008 | 0.000 | 15.50±8.07 | -0.282② | 0.778 | 211.20 (307.15) | -0.330② | 0.741 | | Control group | | | | | | | | | | | | | | Baseline | 1.87±0.38 | ‒ | ‒ | 2.21±0.25 | ‒ | ‒ | 13.87±6.45 | ‒ | ‒ | 147.05 (194.33) | ‒ | ‒ | | 3-month | 1.79±0.53 | -1.132② | 0.257 | 2.39±0.30 | -2.571② | 0.010 | 16.14±9.48 | -1.087② | 0.277 | 176.50 (270.35) | 0.000② | >0.999 | | 6-month | 1.84±0.46 | -0.202 | 0.842 | 2.32±0.19 | 2.06 | 0.054 | 15.90±11.08 | -0.563② | 0.573 | 148.60 (189.88) | -0.675 | 0.509 | | 9-month | 2.23±0.57 | -2.178② | 0.029 | 2.34±0.22 | -2.202② | 0.028 | 12.99±8.14 | -0.679 | 0.506 | 178.50 (209.18) | -0.081 | 0.936 |
|
|
|